Sign in
4

Changes in Ownership

ADC Therapeutics SA Filed Acc 0001628280-25-005860

Chief Financial Officer acquired 240,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Carmona Jose Chief Financial Officer 2025-02-13 Grant or award +240,000 $1.61 $386,400 541,892 D
Loading xslF345X05/wk-form4_1739575294.xml…